CRCT - Centre de Recherches en Cancérologie de Toulouse
  • Center
    • Discover the Center
    • CRCT News
    • Annual report
    • Governance
    • Institutions and partners
    • Support services
    • The Scientific Events Committee
    • Directory
    • Publications
    • Events
    • Contact & Map
  • Research
    • Research lines and medico-scientific programs
      • General presentation medico scientific programs
      • Research lines
      • Medico-scientific programs
    • Research teams
      • 01 M. Ayyoub
      • 02 J.S. Hoffmann
      • 03 G. Favre
      • 04 T. Levade / N. Andrieu
      • 05. S.Millevoi
      • 06 S. Pyronnet / C. Bousquet
    •  
      • 07 P. Brousset / F. Meggetto
      • 08 S.Manenti
      • 09 J.J. Fournié
      • 10 P. Cordelier
      • 11 E. Cohen-Jonathan Moyal / C. Toulas
      • 12 M. Poirot / S. Silvente-Poirot
      • 13 H. Avet-Loiseau / L. Martinet
    •  
      • 14 E. Chatelut
      • 15 M. Bardiès
      • 16 E. Delabesse
      • 17 J. Guillermet-Guibert / J.P. Delord
      • 18 J.E. Sarry
      • 19 F. Chibon
      • 20 S. Valitutti
      • 21 V. Pancaldi
  • CRCT/IUCT-O’s Programs
    • General aims of the programs
    • Our ongoing programs
  • Technology
    • General presentation technology
    • Technology Cluster’s website
  • Fr
  • En
Select Page
Focus: Anti-TNF[alpha] antibodies improve immunotherapy in melanoma

Focus: Anti-TNF[alpha] antibodies improve immunotherapy in melanoma

by Sébastien Guibert | 16 Mar 2018 | Actualités générales

Melanoma is a poor-prognosis skin cancer. Immunotherapy based on the use of monoclonal antibodies (anti-CTLA-4 and anti-PD-1) activates the immune system to fight melanoma and has improved the prognosis of this cancer. Those antibodies block checkpoints, which act as...
Open position: post-doctoral fellow (team 19)

Open position: post-doctoral fellow (team 19)

by Sébastien Guibert | 11 Dec 2017 | Actualités générales

A 2-years post-doctoral position is open in CRCT’s team 19 (ONCOSARC / F. Chibon), starting 01/01/2018 Description The ONCOSARC team of CRCT is focused on deciphering pleomorphic sarcoma oncogenesis. Since these tumors are characterized by a highly rearranged...

News

  • IMLINFO / Cross-border Network of Personalized Immunotherapies for Non-Hodgkin’s Lymphomas
  • Publication team 2 (J.S. Hoffmann) / ARTEMIS and XPF-ERCC1: 2 nucleases to prevent genetic instability
  • Focus: collaboration between Pierre Cordelier’s team & Neovirtech on oncolitic viruses
  • Focus: IMMUSPHINX program – Targeting sphingolipid metabolism to improve the efficacy of immunotherapies in melanoma
  • Focus: Anti-TNF[alpha] antibodies improve immunotherapy in melanoma
  • Contact & Map
  • Legal statements
  • RSS
© Conception & Design Agence CosiWeb
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site web. Si vous continuez à utiliser ce site, nous supposerons que vous en êtes satisfait.Ok